Analyst Price Targets — WAT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 10:10 am | Evie Koslosky | Goldman Sachs | $425.00 | $373.22 | TheFly | Waters price target raised to $425 from $380 at Goldman Sachs |
| July 9, 2026 11:00 am | Kallum Titchmarsh | Morgan Stanley | $390.00 | $368.13 | TheFly | Waters price target raised to $390 from $350 at Morgan Stanley |
| July 8, 2026 8:41 pm | — | RBC Capital | $435.00 | $368.13 | TheFly | Waters initiated with an Outperform at RBC Capital |
| July 6, 2026 12:49 pm | — | Evercore ISI | $410.00 | $375.39 | TheFly | Waters price target raised to $410 from $380 at Evercore ISI |
| June 11, 2026 9:52 am | — | Piper Sandler | $400.00 | $363.18 | TheFly | Waters initiated with a Neutral at Piper Sandler |
| June 3, 2026 9:27 am | — | HSBC | $435.00 | $371.93 | TheFly | Waters price target raised to $435 from $415 at HSBC |
| May 7, 2026 12:42 pm | — | Deutsche Bank | $350.00 | $351.33 | TheFly | Waters price target raised to $350 from $330 at Deutsche Bank |
| May 7, 2026 9:42 am | — | Barclays | $425.00 | $349.53 | TheFly | Waters price target raised to $425 from $400 at Barclays |
| May 6, 2026 1:41 pm | — | UBS | $375.00 | $352.64 | TheFly | Waters price target raised to $375 from $330 at UBS |
| May 6, 2026 10:56 am | — | Robert W. Baird | $387.00 | $342.75 | TheFly | Waters price target raised to $387 from $362 at Baird |
Latest News for WAT
SEATTLE--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence platform, today announced it has been named “Best Alternative Data Provider” in the Waters Technology Rankings 2026. The award, presented by Waters Technology, a leading publication covering financial technology and data for global capital markets, was decided by crowd-sourced votes from industry professionals across the capital…
Waters Corporation remains a Hold as valuation concerns are balanced by ongoing synergy capture from its Becton, Dickinson acquisition. WAT's Q1 pro forma sales rose to $1.54B, with legacy revenue up 13% and recurring revenue surging 123%, signaling broad-based growth. Synergy realization is on track, with $55M+ cost savings and $50M revenue synergies targeted for 2026, supporting incremental EBITDA gains.
MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m.
LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a strategic partnership to accelerate the development of IMU's next-generation AI-powered High Definition (HD) Immunology platform.The partnership brings together Waters Biosciences' advanced flow…
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.